248 related articles for article (PubMed ID: 26447927)
1. Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII.
Gurda BL; De Guilhem De Lataillade A; Bell P; Zhu Y; Yu H; Wang P; Bagel J; Vite CH; Sikora T; Hinderer C; Calcedo R; Yox AD; Steet RA; Ruane T; O'Donnell P; Gao G; Wilson JM; Casal M; Ponder KP; Haskins ME
Mol Ther; 2016 Feb; 24(2):206-216. PubMed ID: 26447927
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII.
Sleeper MM; Fornasari B; Ellinwood NM; Weil MA; Melniczek J; O'Malley TM; Sammarco CD; Xu L; Ponder KP; Haskins ME
Circulation; 2004 Aug; 110(7):815-20. PubMed ID: 15289379
[TBL] [Abstract][Full Text] [Related]
3. Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs.
Mango RL; Xu L; Sands MS; Vogler C; Seiler G; Schwarz T; Haskins ME; Ponder KP
Mol Genet Metab; 2004 May; 82(1):4-19. PubMed ID: 15110316
[TBL] [Abstract][Full Text] [Related]
4. Effect of neonatal gene therapy on lumbar spine disease in mucopolysaccharidosis VII dogs.
Smith LJ; Martin JT; O'Donnell P; Wang P; Elliott DM; Haskins ME; Ponder KP
Mol Genet Metab; 2012 Sep; 107(1-2):145-52. PubMed ID: 22510705
[TBL] [Abstract][Full Text] [Related]
5. The effect of neonatal gene therapy with a gamma retroviral vector on cardiac valve disease in mucopolysaccharidosis VII dogs after a decade.
Bigg PW; Sleeper MM; O'Donnell PA; Liu Y; Wu S; Casal ML; Haskins ME; Ponder KP
Mol Genet Metab; 2013 Nov; 110(3):311-8. PubMed ID: 23860311
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy.
Xu L; Mango RL; Sands MS; Haskins ME; Ellinwood NM; Ponder KP
Mol Ther; 2002 Dec; 6(6):745-58. PubMed ID: 12498771
[TBL] [Abstract][Full Text] [Related]
7. Expression in blood cells may contribute to biochemical and pathological improvements after neonatal intravenous gene therapy for mucopolysaccharidosis VII in dogs.
Wang B; O'Malley TM; Xu L; Vite C; Wang P; O'Donnell PA; Ellinwood NM; Haskins ME; Ponder KP
Mol Genet Metab; 2006 Jan; 87(1):8-21. PubMed ID: 16275036
[TBL] [Abstract][Full Text] [Related]
8. Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII.
Frisella WA; O'Connor LH; Vogler CA; Roberts M; Walkley S; Levy B; Daly TM; Sands MS
Mol Ther; 2001 Mar; 3(3):351-8. PubMed ID: 11273777
[TBL] [Abstract][Full Text] [Related]
9. Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice.
Daly TM; Okuyama T; Vogler C; Haskins ME; Muzyczka N; Sands MS
Hum Gene Ther; 1999 Jan; 10(1):85-94. PubMed ID: 10022533
[TBL] [Abstract][Full Text] [Related]
10. Corrective GUSB transfer to the canine mucopolysaccharidosis VII cornea using a helper-dependent canine adenovirus vector.
Serratrice N; Cubizolle A; Ibanes S; Mestre-Francés N; Bayo-Puxan N; Creyssels S; Gennetier A; Bernex F; Verdier JM; Haskins ME; Couderc G; Malecaze F; Kalatzis V; Kremer EJ
J Control Release; 2014 May; 181():22-31. PubMed ID: 24607662
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal AAVrh10 corrects biochemical and histological hallmarks of mucopolysaccharidosis VII mice and improves behavior and survival.
Pagès G; Giménez-Llort L; García-Lareu B; Ariza L; Navarro M; Casas C; Chillón M; Bosch A
Hum Mol Genet; 2019 Nov; 28(21):3610-3624. PubMed ID: 31511867
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs.
Ponder KP; Melniczek JR; Xu L; Weil MA; O'Malley TM; O'Donnell PA; Knox VW; Aguirre GD; Mazrier H; Ellinwood NM; Sleeper M; Maguire AM; Volk SW; Mango RL; Zweigle J; Wolfe JH; Haskins ME
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13102-7. PubMed ID: 12232044
[TBL] [Abstract][Full Text] [Related]
13. AAV-mediated intravitreal gene therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS VII mice.
Hennig AK; Ogilvie JM; Ohlemiller KK; Timmers AM; Hauswirth WW; Sands MS
Mol Ther; 2004 Jul; 10(1):106-16. PubMed ID: 15233947
[TBL] [Abstract][Full Text] [Related]
14. Clinical response to persistent, low-level beta-glucuronidase expression in the murine model of mucopolysaccharidosis type VII.
Donsante A; Levy B; Vogler C; Sands MS
J Inherit Metab Dis; 2007 Apr; 30(2):227-38. PubMed ID: 17308887
[TBL] [Abstract][Full Text] [Related]
15. Adenoviral vector-mediated beta-glucuronidase cDNA transfer to treat MPS VII RPE in vitro.
Verdugo ME; Scarpino V; Moullier P; Haskins ME; Aguirre GD; Ray J
Curr Eye Res; 2001 Nov; 23(5):357-67. PubMed ID: 11910525
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system delivery of helper-dependent canine adenovirus corrects neuropathology and behavior in mucopolysaccharidosis type VII mice.
Ariza L; Giménez-Llort L; Cubizolle A; Pagès G; García-Lareu B; Serratrice N; Cots D; Thwaite R; Chillón M; Kremer EJ; Bosch A
Hum Gene Ther; 2014 Mar; 25(3):199-211. PubMed ID: 24299455
[TBL] [Abstract][Full Text] [Related]
17. Corrective GUSB transfer to the canine mucopolysaccharidosis VII brain.
Cubizolle A; Serratrice N; Skander N; Colle MA; Ibanes S; Gennetier A; Bayo-Puxan N; Mazouni K; Mennechet F; Joussemet B; Cherel Y; Lajat Y; Vite C; Bernex F; Kalatzis V; Haskins ME; Kremer EJ
Mol Ther; 2014 Apr; 22(4):762-73. PubMed ID: 24343103
[TBL] [Abstract][Full Text] [Related]
18. Cloning of the canine beta-glucuronidase cDNA, mutation identification in canine MPS VII, and retroviral vector-mediated correction of MPS VII cells.
Ray J; Bouvet A; DeSanto C; Fyfe JC; Xu D; Wolfe JH; Aguirre GD; Patterson DF; Haskins ME; Henthorn PS
Genomics; 1998 Mar; 48(2):248-53. PubMed ID: 9521879
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs.
Bigg PW; Baldo G; Sleeper MM; O'Donnell PA; Bai H; Rokkam VR; Liu Y; Wu S; Giugliani R; Casal ML; Haskins ME; Ponder KP
Mol Genet Metab; 2013 Nov; 110(3):319-28. PubMed ID: 23856419
[TBL] [Abstract][Full Text] [Related]
20. The effect of neonatal gene therapy on skeletal manifestations in mucopolysaccharidosis VII dogs after a decade.
Xing EM; Knox VW; O'Donnell PA; Sikura T; Liu Y; Wu S; Casal ML; Haskins ME; Ponder KP
Mol Genet Metab; 2013 Jun; 109(2):183-93. PubMed ID: 23628461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
